Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

National Cancer Institute Awards Nearly $4M to University of new Mexico Cancer Center

Published: Wednesday, November 10, 2010
Last Updated: Wednesday, November 10, 2010
Bookmark and Share
The awards support cancer nanotechnology partnership with Sandia Labs.

The National Cancer Institute recently announced two five-year awards totaling nearly $4 million for a partnership between the University of New Mexico Cancer Center and Sandia National Laboratories. One $1.95 million grant will fund the creation of a joint Cancer Nanotechnology Platform Partnership, and another $1.8 million grant will pay for a new Cancer Nanotechnology Training Center to train a new generation of multidisciplinary scientists.

In addition, the state of New Mexico is providing another $2 million to build a lab supporting Sandia Fellow and UNM professor Jeff Brinker’s research, which is devoted to nano-bio materials and nanomedicine. UNM donated more than 4,500 square feet of lab space in the new Centennial Engineering Building for the project, and construction is scheduled to begin December 2010.

“Sandia is proud to be a part of this important undertaking,” said Steve Rottler, chief technology officer and vice president of science and technology at Sandia Labs. “Pairing Sandia’s expertise in materials science with UNM Cancer Center researchers’ knowledge of cancer biology, oncology and clinical attributes provides an ideal setting in which to move forward in our nation’s fight against cancer.”

The awards comprise the second phase of the NCI’s Alliance for Nanotechnology in Cancer Program, which initiated an investment of more than $30 million per year for the next five years to establish Centers of Cancer Nanotechnology Excellence, Cancer Nanotechnology Platform Partnerships, training grants and the Nanotechnology Characterization Laboratory.

The Alliance was founded in 2004 to leverage specific advantages of nanotechnology to improve cancer diagnosis, treatment and prevention. Since then, the Alliance has led to the discovery of many novel technologies, some of which are currently undergoing commercialization and clinical trials.

“The UNM Cancer Center is honored to be the only institution to earn two of these distinguished awards,” said Dr. Cheryl Willman, director and CEO of the UNM Cancer Center. “Partnering with Sandia Labs will allow us to expand our nanotechnology capabilities, as well as provide our students with a multidisciplinary educational experience.”

Brinker, who is co-principal investigator on the grant with Willman and a distinguished professor of chemical and nuclear engineering at UNM, used a Sandia-funded Laboratory Directed Research and Development (LDRD) grant to conduct preliminary research in nanofabrication. The nanostructures he developed form the basis for delivering drugs directly to a wide variety of cancer targets, a method that increases the drug’s effectiveness and reduces side effects.

“The technology I developed with now-Truman Fellow Carlee Ashley and UNM colleagues is really a generic platform to target any arbitrary cancer, so we’ve already written other proposals and are interacting with other cancer research centers throughout the U.S. and Canada, to go after low-outcome cancers like breast, lung, pancreatic, and liver,” Brinker said.

Brinker is also a team leader in the Cancer Nanotechnology Training Center, which is focused on training multidisciplinary scientists at both Sandia and UNM. One such student, Ashley, started working as an undergraduate student in Brinker’s lab in Sandia’s Advanced Materials Laboratory. Brinker then served as her graduate co-advisor with David Peabody of UNM, and Ashley recently earned one of Sandia’s prestigious Truman Fellowships.

“Carlee’s experience was the model for the training grant. Her work was used as the basis for what we’d like to do in the future,” Brinker said. “She went from biochemistry to training in my lab and then chemical engineering. That kind of interdisciplinary training is something that Sandia and UNM are actively encouraging.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Wednesday, July 27, 2016
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Monday, July 18, 2016
Elevated Bladder Cancer Risk in New England and Arsenic in Drinking Water From Private Wells
Researchers have found that drinking water from private wells, may have contributed to the elevated risk of bladder cancer in northern new England.
Tuesday, May 03, 2016
Near-Atomic Resolution of Protein Structure Holds Promise for Drug Discovery
A new study shows that it is possible to use an imaging technique called cryo-electron microscopy to view the architecture of a metabolic enzyme bound to a drug that blocks its activity.
Friday, May 08, 2015
National Cancer Institute Awards Two Lung Cancer CTC Development Contracts to Cynvenio Biosystems, Inc.
Company also announces additional equity investment of $2.0 million.
Tuesday, February 07, 2012
2011 Biospecimen Research Network (BRN) Symposium
The National Cancer Institute's (NCI) Biospecimen Research Network Symposium, "Advancing Cancer Research Through Biospecimen Science," will be held March 28-29, 2011, at the Bethesda North Marriott Hotel & Conference Center in Bethesda, MD
Friday, January 07, 2011
NCI Announces Plans to Reinvigorate Clinical Trials
The National Cancer Institute (NCI) has announced major changes to be made in the long-established Clinical Trials Cooperative Group Program that conducts many of the nationwide trials of new cancer therapies.
Friday, December 24, 2010
Scientists Identify Markers on Human Breast Cancer Cells Linked to Development of a Form of Breast Cancer
The scientists named these human cells with tumor-forming ability in mice, xenograft-initiating cells, or XIC.
Friday, May 21, 2010
Expression of Proteins Linked to Poor Outcome in Women with Ovarian Cancer
The study led by NCI scientists may provide targets for the development of novel therapies for ovarian cancer.
Wednesday, April 21, 2010
Antibodies Against Abnormal Glycoproteins Identified as Possible Biomarkers for Cancer Detection
Scientists have found that cancer patients produce antibodies that target abnormal glycoproteins made by their tumors.
Thursday, February 04, 2010
The Cancer Genome Atlas Identifies Distinct Subtypes of Deadly Brain Cancer
According to study the most common form of malignant brain cancer in adults appears to be four distinct molecular subtypes.
Thursday, January 21, 2010
Diet May Protect Against Gene Changes in Smokers
A new study finds that leafy green vegetables, folate, and multivitamins could serve as protective factors against lung cancer in smokers.
Thursday, January 14, 2010
Gene Mutations Reveal Potential new Targets for Treating a Type of Non-Hodgkin's Lymphoma
Findings provide insight into a mechanism that cancer cells may use to survive.
Tuesday, January 12, 2010
Gene Mutations Reveal Potential new Targets for Treating a Type of Non-Hodgkin's Lymphoma
Findings provide insight into a mechanism that cancer cells may use to survive.
Friday, January 08, 2010
Drug for Multiple Myeloma Demonstrated to Extend Disease-Free Survival
Patients receiving lenalidomide following a blood stem cell transplant had their cancer kept in check longer than placebo receiving patients.
Thursday, December 24, 2009
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!